\-\ Texto\\:\\ \ \(0\)\
\-\ treated\\ with\\ triple\\ antibiotics\\ and\\ delivery\\ if\\ the\\ dead\\ fetus\\.\\ the\\ patient\\ recovered\\ very\\ quickly\\ after\\ the\\ delivery\\ of\\ the\\ dead\\ fetus\\.\ \(0\)\
\-\ rapid\\ development\\ of\\ airspace\\ opacity\\ in\\ the\\ bilateral\\ lungs\\ without\\ significant\\ pulmonary\\ vasculature\\ engorgement\\ or\\ pleural\\ effusions\\.\ \(0\)\
\-\ acute\\ respiratory\\ distress\\ syndrome\ \(0\)\
\-\ pulmonary\\ edema\ \(53\)\
\-\ ards\ \(90\)\
\-\ 25\\ y\\.p\\.\\ woman\\ with\\ 22wga\\ iup\\ with\\ fetal\\ demise\\ now\\ with\\ chorioamnionitis\\ and\\ shortness\\ of\\ breath\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dead\\:\\ 0\\.37063658268165944\ \(0\)\
\-\ fetus\\:\\ 0\\.29807330183709707\ \(0\)\
\-\ delivery\\:\\ 0\\.2678838428508542\ \(0\)\
\-\ 22wga\\:\\ 0\\.22790803698063547\ \(0\)\
\-\ chorioamnionitis\\:\\ 0\\.22790803698063547\ \(0\)\
\-\ engorgement\\:\\ 0\\.19033165015672016\ \(0\)\
\-\ demise\\:\\ 0\\.19033165015672016\ \(0\)\
\-\ ards\\:\\ 0\\.17929333627294208\ \(0\)\
\-\ iup\\:\\ 0\\.17595731960707797\ \(0\)\
\-\ pulmonary\\:\\ 0\\.1737355149762211\ \(0\)\
\-\ quickly\\:\\ 0\\.16800138554964386\ \(0\)\
\-\ triple\\:\\ 0\\.1668908465381897\ \(0\)\
\-\ recovered\\:\\ 0\\.15640163199105586\ \(0\)\
\-\ airspace\\:\\ 0\\.15306561532519172\ \(0\)\
\-\ the\\:\\ 0\\.14218174152262628\ \(0\)\
\-\ vasculature\\:\\ 0\\.1401790477397333\ \(0\)\
\-\ effusions\\:\\ 0\\.13336757396727217\ \(0\)\
\-\ rapid\\:\\ 0\\.13253007607911635\ \(0\)\
\-\ fetal\\:\\ 0\\.132257034955818\ \(0\)\
\-\ opacity\\:\\ 0\\.12400660223352045\ \(0\)\
\-\ development\\:\\ 0\\.11781490785409944\ \(0\)\
\-\ distress\\:\\ 0\\.11480471954257672\ \(0\)\
\-\ shortness\\:\\ 0\\.11427030314147618\ \(0\)\
\-\ respiratory\\:\\ 0\\.11336172977406284\ \(0\)\
\-\ with\\:\\ 0\\.11162268375285934\ \(0\)\
\-\ pleural\\:\\ 0\\.10728220676141927\ \(0\)\
\-\ lungs\\:\\ 0\\.10517511066017302\ \(0\)\
\-\ antibiotics\\:\\ 0\\.10499208409719343\ \(0\)\
\-\ breath\\:\\ 0\\.10445091461749832\ \(0\)\
\-\ very\\:\\ 0\\.10223253541862937\ \(0\)\
\-\ 25\\:\\ 0\\.10095924003931045\ \(0\)\
\-\ now\\:\\ 0\\.09782772394865553\ \(0\)\
\-\ treated\\:\\ 0\\.08874637561043319\ \(0\)\
\-\ syndrome\\:\\ 0\\.08591508346651225\ \(0\)\
\-\ edema\\:\\ 0\\.08499740716071856\ \(0\)\
\-\ of\\:\\ 0\\.0836670217890623\ \(0\)\
\-\ if\\:\\ 0\\.0828031312093618\ \(0\)\
\-\ significant\\:\\ 0\\.08228340637828678\ \(0\)\
\-\ acute\\:\\ 0\\.07709365307115956\ \(0\)\
\-\ bilateral\\:\\ 0\\.07659131652609724\ \(0\)\
\-\ without\\:\\ 0\\.07516982882709239\ \(0\)\
\-\ woman\\:\\ 0\\.07422082108478352\ \(0\)\
\-\ after\\:\\ 0\\.06913500568066731\ \(0\)\
\-\ and\\:\\ 0\\.058896803800402416\ \(0\)\
\-\ or\\:\\ 0\\.049577457663707906\ \(0\)\
\-\ patient\\:\\ 0\\.04635206523668786\ \(0\)\
\-\ in\\:\\ 0\\.03545241090363201\ \(0\)\
